A 14-year-old neutered male Domestic Shorthair cat with d...

This is a common and challenging scenario, Dr. – one we frequently encounter in internal medicine. Managing feline hyperthyroidism in the face of unmasked renal insufficiency requires a delicate balance and a very methodical approach.

First, let's confirm our understanding. A 14-year-old DSH with previous hyperthyroidism, now on methimazole, presents with lethargy and decreased appetite. The key laboratory findings are elevated BUN and creatinine, with a T4 in the low-normal range. This clinical picture is highly suggestive of renal decompensation secondary to the treatment of hyperthyroidism. Hyperthyroidism increases glomerular filtration rate (GFR), which can mask underlying chronic kidney disease (CKD). When the hyperthyroid state is controlled, GFR often decreases, revealing the true renal function.

Here's my approach to managing this patient:

1. Re-evaluate and Confirm Diagnoses

* Renal Disease: Ensure the elevated BUN and creatinine are persistent and not due to dehydration (though lethargy and anorexia suggest otherwise). A urinalysis (specific gravity, sediment) is crucial to stage the CKD. I would also recommend a symmetric dimethylarginine (SDMA) measurement, as it can be a more sensitive indicator of early renal dysfunction.
Thyroid Status: While the T4 is low-normal, we need to ensure it's not too* low, which could also contribute to lethargy. If the T4 is at the very bottom of the reference range, or even slightly below, this reinforces the need for methimazole adjustment. If free T4 by equilibrium dialysis was performed previously, consider repeating it.

2. Methimazole Dosing Adjustment

The primary goal is to find the lowest effective dose of methimazole that controls hyperthyroidism without significantly worsening renal function.

* Initial Reduction: Given the lethargy, anorexia, and elevated renal values, I would recommend an immediate 25-50% reduction in the current methimazole dose. For example, if the cat was on 2.5 mg BID, I might reduce to 1.25 mg BID or even 1.25 mg once daily, depending on the current T4 value and the severity of clinical signs. The formulary lists 1.25-2.5 mg PO BID as a starting range, so we are working within that established therapeutic window.
* Recheck: Recheck total T4, BUN, creatinine, and SDMA in 7-10 days.
* If T4 remains low-normal but renal values are still worsening: Consider a further reduction in methimazole (e.g., to 0.625 mg BID or even q48h if compounding allows).
* If T4 starts to climb back into the hyperthyroid range, but renal values are improving: This indicates you've found a better balance. Monitor closely.
* The "Sweet Spot": Our aim is often a T4 in the mid-to-high normal range, rather than low-normal, to help preserve GFR in these patients. Some specialists even tolerate a slightly elevated T4 if it means better quality of life and stable renal parameters.

3. Concurrent Management of Chronic Kidney Disease (CKD)

As you adjust the methimazole, aggressive management of the newly unmasked CKD is paramount.

* Fluid Therapy: If the cat is dehydrated or anorexic, aggressive fluid therapy (IV or SQ) is crucial to improve renal perfusion and address azotemia.
* Renal Diet: Transition to a renal-specific diet (e.g., Hill's k/d, Royal Canin Renal Support) as soon as possible. These diets are phosphorus-restricted, protein-controlled, and often sodium-restricted, which are beneficial for CKD. Introduce gradually to ensure palatability.
* Phosphate Binders: If serum phosphorus is elevated or high-normal, consider oral phosphate binders (e.g., aluminum hydroxide) with meals.
* Potassium Supplementation: Monitor potassium levels. Hypokalemia is common in feline CKD and can worsen lethargy and anorexia. Supplement as needed (e.g., potassium gluconate).
* Appetite Stimulants/Anti-emetics: Mirtazapine (1.88-3.75 mg PO q24-48h or transdermal) or capromorelin (0.5 mg/kg PO q24h) can help with appetite. Maropitant (1 mg/kg PO/SQ q24h) can address nausea.
* Blood Pressure: Measure blood pressure. Hypertension is common in CKD and requires treatment (e.g., amlodipine) to prevent target organ damage.

4. Alternative Hyperthyroid Treatments

In cases where methimazole significantly compromises renal function, or if the cat becomes difficult to regulate, consider:

* Radioactive Iodine (I-131) Therapy: This remains the gold standard. However, it requires the cat to be off methimazole for 2-4 weeks prior to treatment, and renal values must be stable. This can be a challenge in a cat with active renal decompensation. If renal values stabilize on a lower methimazole dose, I-131 can still be a good long-term option.
* Hill's y/d Diet: This iodine-restricted diet can be effective as sole therapy in some cats, but compliance can be an issue in multi-cat households or if the cat is finicky. It can be considered if the methimazole dose cannot be tolerated at all.

This scenario requires frequent rechecks and titration of both methimazole and CKD therapies. Client education regarding the chronic nature of both diseases and the potential for a guarded prognosis is also essential.

Confidence Level: High confidence — this is a classic internal medicine challenge with well-established management protocols.